Adrestia Therapeutics is Drug Discovery in United Kingdom that focus on proper functioning business. Founded in 2017. They cover business area such as developer, novel therapeutic, damage, diseased or die cell, that suppress, biological change, physician, normality, patient, their health, proper functioning.
2017
( 7 years old in 2024 )
Proper Functioning
-
Moneta Building 280
Babraham Research Campus, Babraham
Cambridge CB22 3AT
England, United Kingdom
Private
developernovel therapeuticdamage, diseased or die cellthat suppressbiological changephysiciannormalitypatienttheir healthproper functioning
* We use standard office opening hours in near Adrestia Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Adrestia Therapeutics is Drug Discovery business from United Kingdom that founded in 2017 (7 years old in 2024), Adrestia Therapeutics business is focusing on Proper Functioning.
Adrestia Therapeutics headquarter office and corporate office address is located in Moneta Building 280 Babraham Research Campus, Babraham Cambridge CB22 3AT England, United Kingdom.
Adrestia Therapeutics was founded in United Kingdom.
In 2024, Adrestia Therapeutics is currently focus on proper functioning sector.
Above is snippet of Google Trends for "proper functioning" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Adrestia Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
